The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

The negotiated prices would then take effect in January of 2028, Merck said in a recent annual SEC filing (PDF ... has already had two drugs picked for the yearly list of drugs subject ...

Merck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug regimen of doravirine/islatravir met its primary efficacy endpoint. The first trial enrolled patients ...

The approvals are backed by Merck’s (NYSE:MRK) LITESPARK-004 and LITESPARK-005 trials, respectively. An expert panel of the EU drug regulator, the European Medicines Agency, endorsed the ...

Also Read: Merck Injects $1 Billion To Expand Vaccine Production In US Merck plans to begin submitting applications for marketing authorization to regulatory agencies by mid-2025.

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

Europe Approves Merck's Cancer Drug For Two Indications On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s (NYSE:MRK) Welireg (belzutifan), an oral hypoxia ...

The company released the topline data from both studies in December 2024. Also Read: Merck Injects $1 Billion To Expand Vaccine Production In US Merck plans to begin submitting applications for ...

Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

preclinical development and translational medicine, Merck Research Laboratories, said in the release. “We continue to explore new ways to build upon our strong foundation in immuno-oncology and ...

Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg. Gilead had the right to ...

DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new facility in North Durham. The $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the ...